ASKA Pharmaceutical Holdings Co.,Ltd.
Notice of Payment Completion for the Transfer-Restricted Stock as Treasury Stock Acquisition
Payment procedures for the disposal of treasury stock as stock compensation have been completed. The disposed shares are 53,600, with a total disposition amount of 121,082,400 yen; the recipients include directors, executive officers, and subsidiary directors/executives, and the event is dated August 12, 2026.
Key Figures
- Disposal shares: 53,600 shares
- Total disposition amount: 121,082,400 yen
- Disposal date: August 12, 2026
AI要約
Overview
This notice concerns the disposal of treasury stock as stock compensation, and reports the completion of payment based on the board of directors' resolution dated July 13, 2026. The target for disposal is 53,600 ordinary shares of the company, with a disposal price of 2,259 yen per share. The date of execution is specified as August 12, 2026. The recipients include a diverse range of internal and external parties such as officers, executives, and subsidiary directors/executives, which could dilute shareholder ownership.
Impact on Shareholders and Future
The disposal of treasury stock, as stock compensation, may have a dilutive effect on the number of outstanding shares. The exact dilution rate is not stated in this material. Uncertainties may include potential carryovers and revisions to the compensation structure, with additional disclosures expected. Note that the payment completion pertains to the execution on August 12, 2026, and related information is referenced to the notice dated July 13, 2026.
Asuka Pharmaceutical Holdings, Inc.
Company overview · Stock price · Financial data · All IR
